Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Baseline labs should be drawn before starting therapy, with follow-up testing at 8-12 weeks to assess response and guide dose adjustments
3 In the largest phase 3a trial, STEP 1, results showed that patients taking Wegovy achieved a mean weight loss of 15 per cent (15 kg) sustained over 68 weeks
Please make sure you call your pharmacy benefit manager (PBM) as they are responsible for managing the prior authorization for your prescription, rather than your medical insurance network
Specific Side Effects of Oral Formulation: Gastrointestinal Problems : Oral semaglutide is likely to produce slightly more gastrointestinal side effects compared to injectables
For example, the medication can lead to decreased fluid and fiber intake due to changes in appetite and food preferences
Because of its dual mechanism, tirzepatide often produces greater average weight loss and stronger blood sugar improvements in many patients
